Arnold DL - Search Results

1

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group. Comi G, et al. Among authors: arnold dl. Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316. Ann Neurol. 2011. PMID: 21280077 Clinical Trial.

2

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP. Arnold DL, et al. Ann Neurol. 1994 Jul;36(1):76-82. doi: 10.1002/ana.410360115. Ann Neurol. 1994. PMID: 8024266

3

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.

Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, Antel JP, Matthews PM, Arnold DL. Narayanan S, et al. Among authors: arnold dl. Ann Neurol. 1997 Mar;41(3):385-91. doi: 10.1002/ana.410410314. Ann Neurol. 1997. PMID: 9066360 Clinical Trial.

4

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient.

De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. De Stefano N, et al. Among authors: arnold dl. Neurology. 1997 Oct;49(4):1138-41. doi: 10.1212/wnl.49.4.1138. Neurology. 1997. PMID: 9339704

5

Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?

Lee MA, Smith S, Palace J, Narayanan S, Silver N, Minicucci L, Filippi M, Miller DH, Arnold DL, Matthews PM. Lee MA, et al. Among authors: arnold dl. Brain. 1999 Jul;122 ( Pt 7):1261-70. doi: 10.1093/brain/122.7.1261. Brain. 1999. PMID: 10388792

6

Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis.

Laule C, Vavasour IM, Whittall KP, Oger J, Paty DW, Li DK, MacKay AL, Arnold DL. Laule C, et al. Among authors: arnold dl. J Neurol. 2003 Aug;250(8):924-31. doi: 10.1007/s00415-003-1115-z. J Neurol. 2003. PMID: 12928910

7

Evidence for use of glatiramer acetate in multiple sclerosis.

Caramanos Z, Arnold DL. Caramanos Z, et al. Among authors: arnold dl. Lancet Neurol. 2005 Feb;4(2):74-5; discussion 76-7. doi: 10.1016/S1474-4422(05)00974-9. Lancet Neurol. 2005. PMID: 15664538 No abstract available.

8

Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.

Filippi M, Falini A, Arnold DL, Fazekas F, Gonen O, Simon JH, Dousset V, Savoiardo M, Wolinsky JS; White Matter Study Group. Filippi M, et al. Among authors: arnold dl. J Magn Reson Imaging. 2005 Jun;21(6):669-75. doi: 10.1002/jmri.20336. J Magn Reson Imaging. 2005. PMID: 15906322 Review.

9

EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.

Filippi M, Rocca MA, Arnold DL, Bakshi R, Barkhof F, De Stefano N, Fazekas F, Frohman E, Wolinsky JS. Filippi M, et al. Among authors: arnold dl. Eur J Neurol. 2006 Apr;13(4):313-25. doi: 10.1111/j.1468-1331.2006.01543.x. Eur J Neurol. 2006. PMID: 16643308

10

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

Chen JT, Collins DL, Atkins HL, Freedman MS, Galal A, Arnold DL; Canadian MS BMT Study Group. Chen JT, et al. Among authors: arnold dl. Neurology. 2006 Jun 27;66(12):1935-7. doi: 10.1212/01.wnl.0000219816.44094.f8. Neurology. 2006. PMID: 16801665 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters